A
Menu
First published June 02, 2021 Application Aachen patent C – Chemistry & metallurgy

TEIPP PEPTIDE VARIANT AND USES THEREOF

Espacenet Family 68766487

Abstract

Novel nucleic acid sequences, vectors, cells, binding agents, peptides and pharmaceutical compositions are provided that are useful as a medicament, for example in the prevention or treatment of cancer or viral infections associated with impaired HLA class I antigen presentation. Corresponding methods and uses are also provided.

Inventors 6

  1. Thorbald van Hall Aachen author as filed: van Hall, Thorbald
  2. Sjoerd H. van der Burg Aachen author as filed: van der Burg, Sjoerd Henricus
  3. Marjit, Koen
  4. van Heil, Thorbald
  5. van der Berg, Sjoerd Henrikus
  6. Margette, Koen

Inventors are linked to an Aachen author when surname and first name match exactly one author.

Applicants

  • Academisch Ziekenhuis Leiden h.o.d.n. LUMC GBS Leiden
  • 莱顿大学医学中心附属莱顿教学医院

Cited papers 23 in the database

Non-patent literature as cited (68)
  • - MONIE, T. P.BRYANT, C. E. ET AL.: "Activating immunity: Lessons from the TLRs and NLRs", TRENDS BIOCHEM. SCI., vol. 34, no. 11, 2009, pages 553 - 561, XP026736003, DOI: 10.1016/j.tibs.2009.06.011
  • - GANGLOFF, M.: "Structure and function of Toll receptors and their ligands", ANNU. REV. BIOCHEM., vol. 76, 2007, pages 141 - 165, XP009128143, DOI: 10.1146/annurev.biochem.76.060305.151318
  • - SPOHN, R.BUWITT-BECKMANN, U. ET AL.: "Synthetic lipopeptide adjuvants and Toll-like receptor 2—Structure-activity relationships", VACCINE, vol. 22, no. 19, 2004, pages 2494 - 2499, XP004515469, DOI: 10.1016/j.vaccine.2003.11.074
  • - BRYANT, C. E.SPRING, D. R. ET AL.: "The molecular basis of the host response to lipopolysaccharide", NAT. REV. MICROBIOL., vol. 8, no. 1, 2010, pages 8 - 14
  • - BARBALAT RLAU LLOCKSLEY R MBARTON G M: "Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands", NAT IMMUNOL., vol. 10, no. 11, 2009, pages 1200 - 7
  • - AKIRA SUEMATSU STAKEUCHI O: "Pathogen recognition and innate immunity", CELL, vol. 124, no. 4, 24 February 2006 (2006-02-24), pages 783 - 801, XP003018351, DOI: 10.1016/j.cell.2006.02.015
  • - KUMAR HKAWAI TAKIRA S: "Toll-like receptors and innate immunity", BIOCHEM BIOPHYS RES COMMUN, vol. 388, no. 4, 30 October 2009 (2009-10-30), pages 621 - 5, XP026601489, DOI: 10.1016/j.bbrc.2009.08.062
  • - R MONJEZIC MISKEYT GOGISHVILIM SCHLEEFM SCHMEERH EINSELEZ IVICSM HUDECEK, LEUKEMIA, 2016
  • - BS JONESLS LAMBF GOLDMANA DI STASI: "Improving the safety of cell therapy products by suicide gene transfer", FRONT PHARMACOL., vol. 5, 2014, pages 254
  • - MEYERS ET AL., CABIOS, vol. 4, 1989, pages 11 - 17
  • - AUSUBEL ET AL.: "Current Protocols in Molecular Biology", 1987, JOHN WILEY AND SONS, INC.
  • - COHEN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 69, 1972, pages 2110
  • - LUCHANSKY ET AL., MOL. MICROBIOL., vol. 2, 1988, pages 637 - 646
  • - JONSSON, U. ET AL., ANN. BIOL. CLIN., vol. 51, 1993, pages 19 - 26
  • - JONSSON, U. ET AL., BIOTECHNIQUES, vol. 11, 1991, pages 620 - 627
  • - JOHNSSON, B. ET AL., J. MOL. RECOGNIT., vol. 8, 1995, pages 125 - 131
  • - JOHNNSON, B. ET AL., ANAL. BIOCHEM., vol. 198, 1991, pages 268 - 277
  • - NEEDLEMAN ET AL., J. MOL. BIOL., vol. 48, 1970, pages 444 - 453
  • - ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410
  • - ALTSCHUL ET AL., NUCL. ACIDS RES., vol. 25, 1997, pages 3389 - 3402
  • - SINGLETONSAINSBURY: "Dictionary of Microbiology and Molecular Biology", 1994, JOHN WILEY AND SONS
  • - HALEMARHAM: "The Harper Collins Dictionary of Biology", 1991, HARPER PERENNIAL
  • - SELIGER, B.MAEURER, M. J.FERRONE, S.: "Antigen-processing machinery breakdown and tumor growth", IMMUNOL TODAY, vol. 21, 2000, pages 455 - 464, XP004216505, DOI: 10.1016/S0167-5699(00)01692-3
  • - KORKOLOPOULOU, P.KAKLAMANIS, L.PEZZELLA, F.HARRIS, A. L.GATTER, K. C.: "Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer", BR J CANCER, vol. 73, 1996, pages 148 - 153
  • - PANDHA, H.RIGG, A.JOHN, J.LEMOINE, N.: "Loss of expression of antigen-presenting molecules in human pancreatic cancer and pancreatic cancer cell lines", CLIN EXP IMMUNOL, vol. 148, 2007, pages 127 - 135
  • - CRESSWELL, P.ACKERMAN, A. L.GIODINI, A.PEAPER, D. R.WEARSCH, P. A.: "Mechanisms of MHC class I-restricted antigen processing and cross-presentation", IMMUNOL REV, vol. 207, 2005, pages 145 - 157
  • - VAN HALL, T. ET AL.: "Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants", NAT MED, vol. 12, 2006, pages 417 - 424
  • - DOORDUIJN, E. M. ET AL.: "TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors", J CLIN INVEST, vol. 126, 2016, pages 784 - 794
  • - MARIJT, K. A. ET AL.: "Identification of non-mutated neoantigens presented by TAP-deficient tumors", J EXP MED, vol. 215, 2018, pages 2325 - 2337, XP009510574, DOI: 10.1084/jem.20180577
  • - VAN DER BURG, S. H.ARENS, R.OSSENDORP, F.VAN HALL, T.MELIEF, C. J.: "Vaccines for established cancer: overcoming the challenges posed by immune evasion", NAT REV CANCER, vol. 16, 2016, pages 219 - 233
  • - KENTER, G. G. ET AL.: "Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia", N ENGL J MED, vol. 361, 2009, pages 1838 - 1847, XP008157144, DOI: 10.1056/NEJMoa0810097
  • - HILF, N. ET AL.: "Actively personalized vaccination trial for newly diagnosed glioblastoma", NATURE, vol. 565, 2019, pages 240 - 245, XP036696006, DOI: 10.1038/s41586-018-0810-y
  • - MASSARELLI, E. ET AL.: "Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial", JAMA ONCOL, vol. 5, 2019, pages 67 - 73
  • - OTT, P. A. ET AL.: "An immunogenic personal neoantigen vaccine for patients with melanoma", NATURE, vol. 547, 2017, pages 217 - 221
  • - TOES, R. E.OFFRINGA, R.BLOM, R. J.MELIEF, C. J.KAST, W. M.: "Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction", PROC NATL ACAD SCI USA, vol. 93, 1996, pages 7855 - 7860, XP001038340, DOI: 10.1073/pnas.93.15.7855
  • - BIJKER, M. S. ET AL.: "CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity", J IMMUNOL, vol. 179, 2007, pages 5033 - 5040
  • - ROSALIA, R. A. ET AL.: "Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation", EUR J IMMUNOL, vol. 43, 2013, pages 2554 - 2565, XP055469177, DOI: 10.1002/eji.201343324
  • - KHAN, S. ET AL.: "Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells", J BIOL CHEM, vol. 282, 2007, pages 21145 - 21159, XP055613005, DOI: 10.1074/jbc.M701705200
  • - BIJKER, M. S. ET AL.: "Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation", EUR J IMMUNOL, vol. 38, 2008, pages 1033 - 1042, XP055345739, DOI: 10.1002/eji.200737995
  • - MARTOGLIO, B.DOBBERSTEIN, B.: "Signal sequences: more than just greasy peptides", TRENDS CELL BIOL, vol. 8, 1998, pages 410 - 415, XP055047993, DOI: 10.1016/S0962-8924(98)01360-9
  • - VANDEBRIEL, R.HOEFNAGEL, M. M.: "Dendritic cell-based in vitro assays for vaccine immunogenicity", HUM VACCIN IMMUNOTHER, vol. 8, 2012, pages 1323 - 1325, XP055416086, DOI: 10.4161/hv.21350
  • - WULLNER, D. ET AL.: "Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics", CLIN IMMUNOL, vol. 137, 2010, pages 5 - 14
  • - PARK, E.RAPOPORT, T. A.: "Mechanisms of Sec61/SecY-mediated protein translocation across membranes", ANNU REV BIOPHYS, vol. 41, 2012, pages 21 - 40
  • - WEINZIERL, A. O. ET AL.: "Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry", EUR J IMMUNOL, vol. 38, 2008, pages 1503 - 1510
  • - ANDERSON, K. S.ALEXANDER, J.WEI, M.CRESSWELL, P.: "Intracellular transport of class I MHC molecules in antigen processing mutant cell lines", J IMMUNOL, vol. 151, 1993, pages 3407 - 3419
  • - WEI, M. L.CRESSWELL, P.: "HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides", NATURE, vol. 356, 1992, pages 443 - 446
  • - GUERMONPREZ, P.VALLADEAU, J.ZITVOGEL, L.THERY, C.AMIGORENA, S.: "Antigen presentation and T cell stimulation by dendritic cells", ANNU REV IMMUNOL, vol. 20, 2002, pages 621 - 667, XP009012587, DOI: 10.1146/annurev.immunol.20.100301.064828
  • - DOORDUIJN, E. M. ET AL.: "T cells specific for a TAP-independent self-peptide remain naive in tumor-bearing mice and are fully exploitable for therapy", ONCOIMMUNOLOGY, vol. 7, 2018, XP055546937, DOI: 10.1080/2162402X.2017.1382793
  • - LINNEMANN, C. ET AL.: "High-throughput identification of antigen-specific TCRs by TCR gene capture", NAT MED, vol. 19, 2013, pages 1534 - 1541, XP055190765, DOI: 10.1038/nm.3359
  • - MASUKO, K.WAKITA, D.TOGASHI, Y.KITA, T.KITAMURA, H.NISHIMURA, T.: "Artificially synthesized helper/killer-hybrid epitope long peptide (H/K-HELP): Preparation and immunological analysis of vaccine efficacy", IMMUNOLOGY LETTERS, vol. 163, no. 1, 2015, pages 102 - 112, XP055331195, DOI: 10.1016/j.imlet.2014.11.016
  • - VARYPATAKI, E.VAN DER MAADEN, K.BOUWSTRA, J.OSSENDORP, F.JISKOOT, W.: "Cationic Liposomes Loaded with a Synthetic Long Peptide and Poly(I:C): a Defined Adjuvanted Vaccine for Induction of Antigen-Specific T Cell Cytotoxicity", THE AAPS JOURNAL, vol. 17, no. 1, 2014, pages 216 - 226, XP035420757, DOI: 10.1208/s12248-014-9686-4
  • - CHEN, X.LI, D.ZHONG, X.CHEN, B.DUAN, Z.WEN, J.: "Induction of multiple cytotoxic T lymphocyte responses in mice by a multiepitope DNA vaccine against dengue virus serotype 1", MICROBIOLOGY AND IMMUNOLOGY, vol. 60, no. 12, 2016, pages 835 - 845
  • - BEYRANVAND NEJAD, E.VAN DER SLUIS, T.VAN DUIKEREN, S.YAGITA, H.JANSSEN, G.VAN VEELEN, P.MELIEF, C.VAN DER BURG, S.ARENS, R.: "Tumor Eradication by Cisplatin Is Sustained by CD80/86-Mediated Costimulation of CD8+ T Cells", CANCER RESEARCH, vol. 76, no. 20, 2016, pages 6017 - 6029, XP055537015, DOI: 10.1158/0008-5472.CAN-16-0881
  • - DOORDUIJN EMSLUIJTER MMARIJT KAQUERIDO BJVAN DER BURG SHVAN HALL T: "T cells specific for a TAP-independent self-peptide remain naive in tumor-bearing mice and are fully exploitable for therapy", ONCOIMMUNOLOGY, vol. 7, no. 3, 20 November 2017 (2017-11-20)
  • - OSSENDORP, F.MENGEDE, E.CAMPS, M.FILIUS, R.MELIEF, C.: "Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors", THE JOURNAL OF EXPERIMENTAL MEDICINE, vol. 187, no. 5, 1998, pages 693 - 702, XP002173925, DOI: 10.1084/jem.187.5.693
  • - RAHIMIAN, S.FRANSEN, M.KLEINOVINK, J.CHRISTENSEN, J.AMIDI, M.HENNINK, W.OSSENDORP, F.: "Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation", JOURNAL OF CONTROLLED RELEASE, vol. 203, 2015, pages 16 - 22, XP029149030, DOI: 10.1016/j.jconrel.2015.02.006
  • - RESSING MEDE JONG JHBRANDT RMDRIJFHOUT JWBENCKHUIJSEN WESCHREUDER GMOFFRINGA RKAST WMMELIEF CJ: "Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma", EUR J IMMUNOL., vol. 29, no. 4, April 1999 (1999-04-01), pages 1292 - 303
  • - ZOM GGKHAN SBRITTEN CMSOMMANDAS VCAMPS MGLOOF NMBUDDEN CFMEEUWENOORD NJFILIPPOV DVVAN DER MAREL GA: "Efficient induction of antitumor immunity by synthetic toll-like receptor ligand-peptide conjugates", CANCER IMMUNOL RES., vol. 2, no. 8, August 2014 (2014-08-01), pages 756 - 64, XP055365921, DOI: 10.1158/2326-6066.CIR-13-0223
  • - ZOM GGWILLEMS MMJHPKHAN SVAN DER SLUIS TCKLEINOVINK JWCAMPS MGMVAN DER MAREL GAFILIPPOV DVMELIEF CJMOSSENDORP F: "Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication", J IMMUNOTHER CANCER, vol. 6, no. 1, 12 December 2018 (2018-12-12), pages 146, XP021263809, DOI: 10.1186/s40425-018-0455-2
  • - ZOM GGWELTERS MJLOOF NMGOEDEMANS RLOUGHEED SVALENTIJN RRZANDVLIET MLMEEUWENOORD NJMELIEF CJDE GRUIJL TD: "TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients", ONCOTARGET, vol. 7, no. 41, 11 October 2016 (2016-10-11), pages 67087 - 67100
  • [XDA] - MARIJT KOEN A ET AL: "Identification of non-mutated neoantigens presented by TAP-deficient tumors", vol. 215, no. 9, 3 September 2018 (2018-09-03), pages 2325 - 2337, XP009510574, ISSN: 1540-9538, Retrieved from the Internet <URL:http://jem.rupress.org/content/215/9/2325> [retrieved on 20180816], DOI: 10.1084/JEM.20180577
  • - ELIEN M. DOORDUIJN ET AL: "T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy", ONCOIMMUNOLOGY, vol. 7, no. 3, 20 November 2017 (2017-11-20), pages e1382793, XP055546937, DOI: 10.1080/2162402X.2017.1382793
  • - MATHIEU GIGOUX ET AL: "Refusing to TAP out: 16 new human TEIPPs identified", THE JOURNAL OF EXPERIMENTAL MEDICINE, vol. 215, no. 9, 21 August 2018 (2018-08-21), US, pages 2233 - 2234, XP055693763, ISSN: 0022-1007, DOI: 10.1084/jem.20181512
  • - MARIJT KOEN A ET AL: "TEIPP antigens for T-cell based immunotherapy of immune-edited HLA class Ilow cancers", MOLECULAR IMMUNOLOGY, PERGAMON, GB, vol. 113, 4 April 2018 (2018-04-04), pages 43 - 49, XP085827279, ISSN: 0161-5890, [retrieved on 20180404], DOI: 10.1016/J.MOLIMM.2018.03.029
  • - GARBOCZI D N ET AL: "HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, vol. 89, no. 9, 15 April 1992 (1992-04-15), pages 3429 - 3433, XP002131059, ISSN: 0027-8424, DOI: 10.1073/PNAS.89.8.3429
  • - GENPEPT: "登录号：WP_008569256.1", GENPEPT, 8 December 2015 (2015-12-08), pages 107 - 115
  • - 汪铭书, 程安春, 陈孝跃, 刘兆宇, 方鹏飞, 郭宇飞: "血清5型鸭疫里氏杆菌在我国的发现及其病原特性研究", 中国兽医科技, no. 09, 25 September 2002 (2002-09-25), pages 16 - 20
  • - Record for GenBank MEB234624, dated 1/3/24, no author indicated, 2 pages as printed; printed from https://www.ncbi.nlm.nih.gov/protein/MEB2346824

Cited patents 13

US201113031546A WO2013120073A1 WO2012048190A1 US2011236406A1 WO2016071758A1 US2009220534A1 WO2007105954A1 WO2007028574A2 WO2013006050A1 CN107428845A WO2018055060A1 CN108779149A CN109963585A